Molecular imaging for depressive disorders (Q30821361)

26 June 2017

title

Molecular imaging for depressive disorders (English)

1 reference

26 June 2017

T-S Lee

1

1 reference

26 June 2017

S Y Quek

series ordinal

2

1 reference

26 June 2017

K R R Krishnan

series ordinal

3

1 reference

26 June 2017

publication date

15 May 2014

1 reference

American Journal of Neuroradiology

26 June 2017

published in

1 reference

26 June 2017

volume

35

1 reference

26 June 2017

issue

6 Suppl

1 reference

26 June 2017

page(s)

S44-54

1 reference

26 June 2017

1 reference

Molecular-genetic imaging based on reporter gene expression

21 January 2018

1 reference

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

21 January 2018

1 reference

The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans

21 January 2018

1 reference

The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse

21 January 2018

1 reference

GABAergic dysfunction in mood disorders.

21 January 2018

1 reference

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

21 January 2018

1 reference

The GABA system in anxiety and depression and its therapeutic potential

21 January 2018

1 reference

Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies

21 January 2018

1 reference

Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.

21 January 2018

1 reference

Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression

21 January 2018

1 reference

Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder

21 January 2018

1 reference

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

21 January 2018

1 reference

Update on the use of MR for assessment and diagnosis of psychiatric diseases

21 January 2018

1 reference

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

21 January 2018

1 reference

Oxidative stress markers in affective disorders.

21 January 2018

1 reference

Depression and oxidative stress: results from a meta-analysis of observational studies

21 January 2018

1 reference

Increased oxidative stress in patients with depression and its relationship to treatment

21 January 2018

1 reference

Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder--a postmortem study

21 January 2018

1 reference

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study

21 January 2018

1 reference

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems

21 January 2018

1 reference

Subgenual prefrontal cortex abnormalities in mood disorders

21 January 2018

1 reference

Stress and depression: possible links to neuron death in the hippocampus

21 January 2018

1 reference

A systematic review of resting-state functional-MRI studies in major depression.

21 January 2018

1 reference

In vivo magnetic resonance spectroscopy: basic methodology and clinical applications

21 January 2018

1 reference

Magnetic resonance spectroscopy: current and future applications in psychiatric research

21 January 2018

1 reference

Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders

21 January 2018

1 reference

Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression?

21 January 2018

1 reference

Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders

21 January 2018

1 reference

31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis

21 January 2018

1 reference

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

21 January 2018

1 reference

Clinical Neuroimaging in Psychiatry

21 January 2018

1 reference

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis

21 January 2018

1 reference

Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy

21 January 2018

1 reference

A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition

21 January 2018

1 reference

Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in depression

21 January 2018

1 reference

Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression.

21 January 2018

1 reference

Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression

21 January 2018

1 reference

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders

21 January 2018

1 reference

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy

21 January 2018

1 reference

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy

21 January 2018

1 reference

Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients

21 January 2018

1 reference

Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model

21 January 2018

1 reference

Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7 T.

21 January 2018

1 reference

Learning and memory alterations are associated with hippocampal N-acetylaspartate in a rat model of depression as measured by 1H-MRS

21 January 2018

1 reference

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

21 January 2018

1 reference

Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression

21 January 2018

1 reference

Molecular tools for assessing human depression by positron emission tomography

21 January 2018

1 reference

Neuroreceptor imaging in depression

21 January 2018

1 reference

Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography

21 January 2018

1 reference

Lower serotonin transporter binding potential in the human brain during major depressive episodes

21 January 2018

1 reference

PET brain imaging with [11C]( )McN5652 shows increased serotonin transporter availability in major depression

21 January 2018

1 reference

Central serotonin transporter levels are associated with stress hormone response and anxiety

21 January 2018

1 reference

Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.

21 January 2018

1 reference

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

21 January 2018

1 reference

Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder

21 January 2018

1 reference

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

21 January 2018

1 reference

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

21 January 2018

1 reference

Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations

21 January 2018

1 reference

Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635.

21 January 2018

1 reference

Serotonin 1A receptor binding and treatment response in late-life depression

21 January 2018

1 reference

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

21 January 2018

1 reference

Serotonin-1A receptor imaging in recurrent depression: replication and literature review

21 January 2018

1 reference

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality

21 January 2018

1 reference

Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression

21 January 2018

1 reference

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study

21 January 2018

1 reference

Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo

21 January 2018

1 reference

Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography

21 January 2018

1 reference

Greater loss of 5-HT(2A) receptors in midlife than in late life

21 January 2018

1 reference

Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis

21 January 2018

1 reference

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks

21 January 2018

1 reference

Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112

21 January 2018

1 reference

Decreased histamine H1 receptor binding in the brain of depressed patients

21 January 2018

1 reference

Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder

21 January 2018

1 reference

Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride

21 January 2018

1 reference

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

21 January 2018

1 reference

Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence

21 January 2018

1 reference

Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression

21 January 2018

1 reference

Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression

21 January 2018

1 reference

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

21 January 2018

1 reference

Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457.

21 January 2018

1 reference

Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.

21 January 2018

1 reference

Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder

21 January 2018

1 reference

Research letter: Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder

21 January 2018

1 reference

Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.

21 January 2018

1 reference

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

21 January 2018

1 reference

Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.

21 January 2018

1 reference

In vivo glutathione levels in young persons with bipolar disorder: a magnetic resonance spectroscopy study

21 January 2018

1 reference

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.3174/AJNR.A3965

1 reference

26 June 2017

1 reference